liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran
Division of Human Genetics, Immunology Research Centre, Bu-Ali Research Institute, Mashhad, Iran.
Department of Paediatrics, Imam Reza Hospital, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran.
Department of Molecular Medicine and Surgery, Centre of Molecular Medicine (CMM) L8:02, Karolinska Institutet/Karolinska University Hospital, Stockholm, Sweden.
Linköping University, The Institute of Technology. Linköping University, Department of Physics, Chemistry and Biology, Applied Physics .
Show others and affiliations
2007 (English)In: Clinical Endocrinology, ISSN 0300-0664, Vol. 67, no 3, 335-341 p.Article in journal (Refereed) Published
Abstract [en]

Objective: Congenital adrenal hyperplasia (CAH) refers to a group of autosomal recessive disorders frequently caused by mutations in the steroid 21-hydroxylase gene (CYP21A2). We describe three novel CYP21A2 mutations in CAH patients. Design and methods: Sequence analysis of the entire CYP21A2 gene followed by molecular modelling was performed in three unrelated classical CAH patients of northeastern Iranian origin. The active (CYP21A2) and pseudogene (CYP21A1P) alleles were screened for the presence of the new variations in controls. Results: Two novel missense mutations, F404S in exon 9 and T450P in exon 10, were found in homozygous forms in two female patients with a salt-wasting (SW) phenotype. These novel variants were screened by allele-specific polymerase chain reaction (PCR) and excluded in 100 unrelated normal alleles. Prediction of clinical severity, based on molecular modelling and sequence conservation, correlates well with the clinical diagnosis of the patients carrying these mutations. The third novel mutation, a small 10-bp deletion in exon 1, g.19_28del, was found in a female patient with a simple virilizing phenotype in a compound heterozygous form with the common intron 2 splice mutation (IVS2-13A/C>G). This frameshift mutation causes a premature stop codon at amino acid position 48, L48X, resulting in a nonfunctional protein. The CYP21A1P pseudogene alleles were also screened and none of these novel mutations could be detected. Conclusions: Three novel mutations were found in the CYP21A2 gene and predicted to drastically impair enzyme activity resulting in severe classic CAH. None of these mutations occurs in the CYP21A1P pseudogene. © 2007 The Authors.

Place, publisher, year, edition, pages
2007. Vol. 67, no 3, 335-341 p.
National Category
Engineering and Technology
URN: urn:nbn:se:liu:diva-48855DOI: 10.1111/j.1365-2265.2007.02886.xOAI: diva2:269751
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Carlsson, Jenny
By organisation
The Institute of TechnologyApplied Physics
In the same journal
Clinical Endocrinology
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 27 hits
ReferencesLink to record
Permanent link

Direct link